Author

C. Sureau

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

M. Muramatsu· 3 shared T. Wakita· 3 shared K. Fukano· 2 shared K. Watashi· 2 shared A. Murayama· 1 shared B. S. Möhl· 1 shared C. Kobayashi· 1 shared F. Bohne· 1 shared

Activity by Year

2018-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

M. Muramatsu

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The kinesin KIF4 mediates HBV/HDV entry through regulation of surface NTCP localization and can be targeted by RXR agonists in vitro.

S. A. Gad, M. Sugiyama, M. Tsuge, K. Wakae, K. Fukano, M. Oshima, C. Sureau, N. Watanabe, T. Kato, A. Murayama, Y. Li, I. Shoji, K. Shimotohno, K. Chayama, M. Muramatsu, , H. H. Aly

This paper identifies KIF4 as a critical regulator of NTCP surface localization for HBV/HDV entry and shows RXR agonists can suppress KIF4 to inhibit viral infection.

bioRxiv · Sep 29, 2021Microbiology

Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxysterol derivatives in vitro

H. Ohashi, F. Wang, F. Stappenbeck, K. Tsuchimoto, C. Kobayashi, W. Saso, M. Kataoka, K. Kuramochi, M. Muramatsu, T. Suzuki, C. Sureau, M. Takeda, T. Wakita, F. Parhami, K. Watashi

This study identifies oxysterol derivatives with anti-SARS-CoV-2 activity, showing that Oxy210 and Oxy232 inhibit viral replication by disrupting double membrane vesicles.

bioRxiv · Jan 31, 2021Microbiology

Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane

L. Zhao, F. Chen, O. Quitt, M. Festag, M. Ringelhan, K. Wisskirchen, J. Hasreiter, L. Yakovleva, C. Sureau, F. Bohne, M. Aichler, V. Bruss, M. Shevtsov, M. A. van de Klundert, F. Momburg, , U. Protzer

This study shows HBV envelope proteins are present on the host cell plasma membrane and can be targeted by T-cells for therapeutic purposes.

bioRxiv · Dec 21, 2020Microbiology

A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species-specificity

J. S. Takeuchi, K. Fukano, M. Iwamoto, S. Tsukuda, R. Suzuki, H. Aizaki, M. Muramatsu, T. Wakita, C. Sureau, K. Watashi

The paper shows a single mutation in the NTCP receptor determines HBV infection specificity by showing how virus-induced positive selection at aa 158 alters host susceptibility.

bioRxiv · Aug 20, 2018Evolutionary Biology